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Abstract
Background: Japanese encephalitis virus (JEV), as a re-emerging virus that causes 10,000-15,000 human deaths
from encephalitis in the world each year, has had a significant impact on public health. Pigs are the natural
reservoirs of JEV and play an important role in the amplification, dispersal and epidemiology of JEV. The
nonstructural protein 3 (NS3) of JEV possesses enzymatic activities of serine protease, helicase and nucleoside 5’-
triphosphatase, and plays important roles in viral replication and pathogenesis.
Results: We characterized the NS3 protein of a neurovirulent strain of JEV (SH-JEV01) isolated from a field-infected
pig. The NS3 gene of the JEV SH-JEV01 strain is 1857 bp in length and encodes protein of approximately 72 kDa
with 99% amino acid sequence identity to that of the representative immunotype strain JaGAr 01. The NS3 protein
was detectable 12 h post-infection in a mouse neuroblastoma cell line, Neuro-2a, and was distributed in the
cytoplasm of cells infected with the SH-JEV01 strain of JEV. In the brain of mice infected with the SH-JEV01 strain
of JEV, NS3 was detected in the cytoplasm of neuronal cells, including pyramidal neurons of the cerebrum, granule
cells, small cells and Purkinje cells of the cerebellum.
Conclusions: The NS3 protein of a neurovirulent strain of JEV isolated from a pig was characterized. It is an
approximately 72 kDa protein and distributed in the cytoplasm of infected cells. The Purkinje cell of the cerebellum
is one of the target cells of JEV infection. Our data should provide some basic information for the study of the role
of NS3 in the pathogenesis of JEV and the immune response.
Background
Japanese encephalitis (JE), known previously as Japanese
B encephalitis, is caused by Japanese encephalitis virus
(JEV). JE is most prevalent in Southeast Asia and the
Far East, and causes 10,000-15,000 human deaths from
encephalitis in the world each year [1]. JEV is a mos-
quito-borne virus of the Flavivirus genus in the family
Flaviviridae. Its genome is positive-sense single-stranded
RNA, approximately 11 kb in length, which encodes a
precursor polyprotein consisting of three structural pro-
teins (C, prM and E) and seven nonstructural proteins
(NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) [2].
The nonstructural protein 3 (NS3) of JEV is a multi-
functional protein of 619 amino acid residues. It pos-
sesses enzymatic activities of serine protease, helicase
and nucleoside 5’-triphosphatase, and plays important
roles in the processing of the viral precursor polyprotein
and the replication of viral genomic RNA [3]. In JEV-
infected cells, NS3 is associated with microtubules and
tumor susceptibility gene 101 protein, which play essen-
tial roles in viral RNA packaging, intracellular trafficking
of viral components and viral assembly [4-6]. NS3 is
localized mainly at the JEV-induced convoluted mem-
brane, a membrane vesicle structure, which has been
proposed to originate from rough endoplasmic reticu-
lum, Golgi apparatus or the trans-Golgi network, and
serves as a reservoir for viral proteins during virus
assembly [6]. Therefore, NS3 has been considered to be
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potent therapeutic substances [7].
In addition to humans, other mammalian animals and
birds are susceptible to JEV. Infection with JEV causes
reproductive disorders, such as orchitis, stillbirths and
mummified fetuses, in breeding pigs and encephalitis in
piglets, but no observable clinical signs in growing and
adult pigs. The JEV-infected pigs develop a level of viremia
that remains high enough to infect mosquitoes for up to 4
days [8]. Pigs are the major amplifying hosts of JEV, and
also act as maintenance hosts in endemic areas [9]. Despite
the fact that pigs play an important role in the amplifica-
tion, dispersal and epidemiology of JEV, JEV strains iso-
l a t e df r o mp i g sh a v en o tb e e ns t u d i e dt h o r o u g h l y .
In this study, we characterized the NS3 protein of a
neurovirulent strain of JEV (SH-JEV01) isolated from a
field-infected pig, because NS3 is a multifunctional pro-
tein that plays important roles not only in viral replica-
tion, as described above, but also in the host immune
response and pathogenesis. Previous studies have
demonstrated that NS3 is a dominant CD4+ as well as
CD8+ T cell-eliciting antigen [10] and is able to induce
caspase 3 activation and mitochondria-mediated apopto-
sis in human medulloblastoma cells [11]. The character-
ization of the NS3 protein of the JEV strain isolated
from pigs should provide some basic information for the
study of its role in the pathogenesis of JEV and the
immune response.
Results
Cloning and expression of the NS3 gene
The gene encoding the full-length NS3 protein of JEV
SH-JEV01 strain was amplified from JEV-infected cells
by reverse transcription-polymerase chain reaction (RT-
PCR). The amplified products were 1857 bp in length
(Figure 1A) and confirmed by DNA sequencing. The
amino acid sequence deduced from the nucleotide
sequence of NS3 consists of 619 amino acid residues
and showed 99% identity to that of the representative
immunotype strain JaGAr 01 (GenBank No: AF069076).
To express a truncated NS3 protein in prokaryotic cells
for generation of antibodies against NS3, a segment
encoding the C-terminal region of NS3 (NS3c) was sub-
cloned into the expression vector pET-28a (Figure 1B).
T h eN S 3 cp r o t e i nw a se x p r e s s e di nEscherichia coli
(Figure 1C, lane 2) and purified by Ni
2+ affinity chroma-
tography using Ni-NTA beads. Peak A280 fractions
eluted from the column were pooled and showed a pre-
dominant single His-NS3c band (Figure 1C, lane 3).
Generation of polyclonal antibodies against NS3
The purified His-NS3c was injected into mice for pro-
duction of antibodies. The titer of the antiserum col-
lected at 7 days after the fourth immunization was
determined by enzyme-linked immunosorbent assay
(ELISA) (data not shown). The antiserum with the high-
est ELISA titer (1:128,000) was temporarily designated
“anti-NS3 antibody” and used for subsequent experi-
ments. To test the specificity of the anti-NS3 antibody,
Neuro-2a cells were transfected transiently with the
plasmid Flag-NS3 and subjected to western blot and
immunofluorescence analysis using the anti-NS3 anti-
body. A plasmid expressing the Flag-tagged NS5 protein
of JEV (Flag-NS5) was used as the control. The western
blot analysis revealed that the anti-NS3 antibody reacted
specifically with the Flag-NS3 protein expressed in
Figure 1 Cloning and expression of the NS3 gene. (A) NS3 gene was amplified from JEV-infected cells by RT-PCR and checked by agarose
gel electrophoresis. Lane M, DNA ladder. (B) The recombinant plasmid expressing the C-terminal region of the NS3 protein (NS3c) was double
digested with EcoR I and Sal I and separated by agarose gel electrophoresis. Lane M, DNA ladder; Lane Vec, pET-28a empty vector; Lane NS3c,
recombinant plasmid expressing NS3c protein. (C) Analysis of the expression and purification of His-tagged NS3c (His-NS3c). Bacterial lysates and
purified His-NS3c were separated on a 10% SDS-PAGE gel and stained with Coomassie blue R250. Lane 1, uninduced bacterial cells; lane 2,
bacterial cells induced with isopropyl-b-D-thiogalactopyranoside (IPTG); Lane 3, His-NS3c eluted from the His Bind Resin column.
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Page 2 of 10Neuro-2a cells (Figure 2A). The immunofluorescence
analysis demonstrated that the anti-NS3 antibody
stained the Neuro-2a cells transfected with the plasmid
Flag-NS3 (Figure 2B). Taken together, these results indi-
cated that the anti-NS3 antibody is highly specific and is
able to detect the NS3 protein.
Expression of NS3 in JEV-infected cells and mouse brains
The mouse neuroblastoma cell line Neuro-2a has been
used for JEV studies [12,13], so we used Neuro-2a cells
for analysis of NS3 expression by western blot. The NS3
protein expressed in cells infected with the SH-JEV01
strain of JEV has a molecular mass of approximately 72
kDa (Figure 3A), which is similar to that of the RP9
strain [6]. We also detected the NS3 protein in the
brain homogenates of mice infected with the SH-JEV01
strain of JEV. A single band of 72 kDa corresponding to
NS3 was detected (Figure 3B). The dynamics of NS3
expression during infection of Neuro-2a cells were
determined at various times post-infection (hpi) by wes-
tern blot analysis; as shown in Figure 3C, the expression
of NS3 was detectable from 12 hpi with a gradually
increasing pattern.
Intracellular localization of NS3 in JEV-infected cells
To detect the intracellular localization of NS3, Neuro-
2a cells were infected with the SH-JEV01 strain of JEV
and the intracellular localization of NS3 was detected
at various times post-infection by immunofluorescence
analysis. As shown in Figure 4A, the NS3 protein,
shown as red fluorescence, appeared from 6 hpi at the
perinuclear cytoplasm region of JEV-infected cells
Figure 2 Analysis of the specificity of the anti-NS3 antibody produced. (A) Western blot analysis of Flag-NS3 expressed in Neuro-2a cells.
Cell lysates (20 μg) from Neuro-2a cells transfected with plasmid expressing Flag-NS3 were probed with the anti-NS3 antibody (anti-NS3 panel)
and then re-probed with anti-Flag antibody (M2, Sigma) (anti-Flag panel). The plasmid expressing Flag-tagged JEV NS5 protein (Flag-NS5) and
Flag-empty vector (Flag-vector) were used as controls. (B) Immunofluorescence analysis of Flag-NS3 expressed in Neuro-2a cells. Neuro-2a cells
transfected with plasmid expressing Flag-NS3 were double-immunostained with the anti-NS3 antibody (anti-NS3 panel, red) and anti-Flag
antibody (anti-Flag panel, green). The cells transfected with plasmid expressing Flag-tagged JEV NS5 protein (Flag-NS5) were used as controls.
The cells were also stained for DNA with 4’,6 ’-diamidino-2-phenylindole (DAPI) (DAPI panel, blue). Merge panel shows the superimposed image.
Bar, 20 μm.
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emanated into the cytoplasm with increased time post-
infection (panels c and d). At 48 hpi, NS3 was distrib-
uted widely in the cytoplasm, including the neuroden-
drites (panel e). No significant fluorescence was
observed in mock-infected cells (panel a). The cyto-
plasmic distribution of the NS3 was also observed in
porcine vascular endothelial cells (PIEC) infected with
t h eS H - J E V 0 1s t r a i no fJ E V( F i g u r e4 B ) .
Localization of NS3 in mouse brain cells
To detect the localization of NS3 in brain cells of mice
infected with the SH-JEV01 strain of JEV, brain sections
from JEV-infected mice were stained immunohisto-
chemically with the anti-NS3 antibody. The nuclei were
counter-stained with hematoxylin, which shows light or
dark blue. The NS3 protein, shown as brown deposits
by immunoperoxidase stains, was found to be distribu-
ted in the cytoplasm of neuronal cells in the cerebrum;
a higher NS3-positive rate was detected in the pyramidal
neurons of the cerebral cortex (Figure 5A, JEV panel).
The neuronal cells of the mock-infected mice did not
show visible staining for NS3 protein (Figure 5A, Mock
panel). The NS3 protein was not detectable in the cere-
bellum of the mock-infected mice (data not shown). In
contrast, NS3 protein was found in the cytoplasm of
neuronal cells of the deep nuclei (panel a), small cells of
the molecular layer (panel b) and granule cells of the
granular layer (panel c) of the cerebellum of JEV-
infected mice (Figure 5B).
Detection of NS3 in Purkinje cells
Purkinje cells are long-axon neurons in the cerebellum
and function as the sole output cells of the cerebellar
cortex. Abnormalities in cerebellar Purkinje cells result
in neurological signs such as ataxia [14]. The mice
infected with the SH-JEV01 strain of JEV showed clini-
cal signs of ataxia in our experiments (data not
shown); we therefore detected the NS3 protein in Pur-
kinje cells using immunohistochemical analysis. The
NS3 staining was detected in the cytoplasm of certain
Purkinje cells of JEV-infected mice, with a positive rate
of 15.3% (Figure 6, JEV panel; Figure 5B, panel d), but
not in the cells of the mock-infected mice (Figure 6,
Mock panel), which suggests that Purkinje cells are
infected by JEV.
Figure 3 Detection of the expression of NS3 by western blot analysis. The lysates from JEV-infected cells or mouse brains were
immunoblotted with the anti-NS3 antibody and re-probed with anti-b-actin antibody (AC-15, Sigma). (A) Neuro-2a cells were infected with the
SH-JEV01 strain of JEV at MOI 5 and analyzed 12 h post-infection (hpi). Mock-infected cells (Mock) were used as controls. (B) Brain homogenates
from mice infected with the SH-JEV01 strain of JEV (1.0 × 10
6 PFU) were analyzed by western blot. Brain homogenates from the mock-infected
mice (Mock) were used as controls. Lane 1#, 2# and 3#, number of JEV-infected individual mice. (C) Neuro-2a cells were infected with the SH-
JEV01 strain of JEV at MOI 5 and analyzed at the indicated times.
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Page 4 of 10Figure 4 Analysis of the intracellular localization of NS3. Neuro-2a (A) and PIEC cells (B) were infected with the SH-JEV01 strain of JEV and
immunostained with anti-NS3 antibody (red) at the indicated times. Mock-infected cells (Mock) were used as controls. The cells were also
stained for DNA with 4’,6 ’-diamidino-2-phenylindole (DAPI) (blue). Merge panel shows the superimposed image. hpi, hours post-infection. Bar,
20 μm.
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Page 5 of 10Figure 5 Detection of NS3 in mouse brain cells. One-week-old sucking mice were infected with the SH-JEV01 strain of JEV (1.0 × 10
6 PFU).
Brain samples were collected from mice showing neurological signs and stained immunohistochemically with the anti-NS3 antibody. The nuclei
were counter-stained by hematoxylin. Brain samples from the mock-infected mice (Mock) were used as controls. (A) Immunohistochemical
examination of the cerebral cortex. Bar, 50 μm. (B) Immunohistochemical examination of the cerebellum. Bar, 200 μm. Arrows indicate the NS3-
positive cells.
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Pigs are the natural reservoirs of JEV, and JEV-infected
pigs act as important amplifying hosts of JEV [15]. Pigs
infected with JEV develop a level of viremia that makes
the virus available to mosquitoes [8]. Despite the fact
that pigs play an important role in the amplification,
dispersal and epidemiology of JEV, JEV strains isolated
from pigs have not been studied thoroughly. In this
study, we used the mouse neuroblastoma cell line
Neuro-2a and mouse models to characterize the NS3
protein, a multifunctional protein that plays important
roles in viral replication and pathogenesis, of a neuro-
virulent strain of JEV (SH-JEV01) isolated from a field-
infected pig.
T h eN S 3g e n eo ft h eS H - J E V 0 1s t r a i no fJ E Vi s1 8 5 7
bp in length (Figure 1A). The amino acid sequence
deduced from the nucleotide sequence of NS3 consists
of 619 amino acid residues and shows 99% identity to
that of the representative immunotype JaGAr 01 strain
(GenBank No: AF069076). The JaGAr 01 strain was iso-
lated from Culex m o s q u i t o e si nJ a p a ni n1 9 5 9a n di s
neurovirulent and neuroinvasive [16]. The molecular
mass of the NS3 of the SH-JEV01 strain of JEV was
approximately 72 kDa, as measured by western blot ana-
lysis (Figure 3A and 3B), which is similar to that of the
RP9 strain [6]. The NS3 protein was detectable 12 hpi
in Neuro-2a cells and was distributed in the cytoplasm
of infected cells (Figure 4), which is in agreement with
previous studies [4,6]. In the brain of JEV-infected mice,
NS3 was detected in the cytoplasm of neuronal cells,
including pyramidal neurons of the cerebrum (Figure 5),
granule cells, small cells and Purkinje cells of the cere-
bellum (Figure 5 and 6), which is similar to the findings
of previous studies [4] and suggested that the SH-JEV01
strain of JEV is neurovirulent and neuroinvasive in suck-
ing mouse.
C e r e b e l l a rP u r k i n j ec e l l sa r ec r i t i c a lf o rt h en o r m a l
function of the cerebellum. Abnormalities in cerebellar
Purkinje cells result in neurological signs such as ataxia
[15]. We found that 15.3% of cerebellar Purkinje cells
were positive for NS3 staining (Figure 5B, panel d and
Figure 6), which suggests that the Purkinje cell is one of
the target cells of JEV infection. However, whether JEV
infects cerebellar Purkinje cells is disputed, because
Wang et al. [4] and Johnson et al. [17] demonstrated no
viral antigens in cerebellar Purkinje cells, whereas Desai
et al. [18] found that viral antigens were present in Pur-
kinje cells. This controversy is presumably due to the
differences in virulence and cell tropism between JEV
strains. The JEV strain that did not infect cerebellar
Purkinje cells in the study of Wang et al. [4] is a mutant
strain developed by g-ray irradiation, which mainly tar-
gets the cerebrum rather than the cerebellum [4]. In
contrast, the JEV stain used in our study is a neuroviru-
lent strain, which causes severe signs of encephalitis,
including ataxia, in the mouse. Purkinje cells are the
major output neurons of the cerebellar cortex and pro-
vide inhibitory feedback into the deep cerebellar nuclei
[15]. Our data indicated that the Purkinje cells were tar-
geted by JEV, suggesting a potential role of the infected
Purkinje cells in JEV neuropathogenesis. However, the
significance of JEV-infected Purkinje cells in the viral
neuropathogenesis needs to be further explored.
NS3 has been described to be involved in the activa-
tion of caspase 3 and mitochondria-mediated apoptosis
[11]. We attempted to determine whether NS3 is loca-
lized in mitochondria, which play an important role in
the regulation of apoptosis, by immunofluorescence ana-
lysis. In the JEV-infected Neuro-2a cells, the co-localiza-
tion of NS3 and GRP75, a mitochondrial protein [19],
was not observed (data not shown), which implies that
NS3 does not localize in mitochondria. In addition, no
Figure 6 Detection of NS3 in Purkinje cells. One-week-old sucking mice were infected with the SH-JEV01 strain of JEV (1.0 × 10
6 PFU).
Samples were collected from the cerebellum of mice showing the neurological signs and stained immunohistochemically with the anti-NS3
antibody. The nuclei were counter-stained by hematoxylin. Cerebellar samples from the mock-infected mice (Mock) were used as controls.
Arrows indicate Purkinje cells. Bar, 50 μm.
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testes that were collected from the JEV SH-JEV01-
infected mice at necropsy (data not shown), although
the mice had been inoculated intraperitoneally with JEV.
Conclusions
In conclusion, we characterized the NS3 protein of a
neurovirulent strain of JEV (SH-JEV01) isolated from a
field-infected pig. The NS3 gene of the JEV SH-JEV01
strain is 1857 bp in length and encodes protein of
approximately 72 kDa. The NS3 protein was detectable
12 h post-infection in a mouse neuroblastoma cells, and
was distributed in the cytoplasm of cells infected with
t h eS H - J E V 0 1s t r a i no fJ E V .I nt h eb r a i no fm i c e
infected with the SH-JEV01 strain of JEV, NS3 was
detected in the cytoplasm of neuronal cells, including
pyramidal neurons of the cerebrum, granule cells, small
cells and Purkinje cells of the cerebellum. Our data
should provide some basic information for the study of
its role in the pathogenesis of JEV and the immune
response.
Methods
Virus and cells
A neurovirulent strain of JEV (SH-JEV01), isolated from
aborted fetuses of sow, was grown in 3-day-old BALB/c
mice and titrated by plaque assay using a baby-hamster
kidney cell line (BHK-21). A mouse neuroblastoma cell
line, Neuro-2a (ATCC No. CCL-131), PIEC and BHK-
21 cells were grown in Dulbecco’s modified Eagle’s med-
ium (DMEM) supplemented with 10% fetal bovine
serum (FBS) at 37°C in an atmosphere containing 5%
CO2.
Viral infection
Neuro-2a, PIEC and BHK-21 cells were pre-cultured on
6-well plates overnight. The cells were inoculated with
the SH-JEV01 strain of JEV at a multiplicity of infection
(MOI) of 5 when the cells reached approximately 50-
70% confluence. The inoculum was removed following a
1.5 h period of incubation, and the cells were further
incubated in DMEM with 1% FBS for the indicated
times.
Cloning and expression
A sequence encoding the full length of the JEV NS3
protein was amplified from BHK-21 cells infected with
the SH-JEV01 strain of JEV by reverse transcription
(RT) using 6 bp random primers and polymerase chain
reaction (PCR) with NS3 specific primers (forward 5’-
ATGAATTCAGGGGGCGTGTTTTG-3’,r e v e r s e5 ’-
GCGTCGACTTATCTCTTCCCTGCTGCA-3’). The
RT-PCR product was analyzed by DNA sequencing, and
was inserted subsequently into the EcoR I-Sal I cloning
site of a eukaryotic expression vector, p3xFLAG-CMV-
7.1 (Sigma, St. Louis, MO, USA) to generate the
recombinant plasmid Flag-NS3. Transfection of plasmid
Flag-NS3 into Neuro-2a cells was performed using Lipo-
fectamine™ 2000 (Invitrogen, Carlsbad, CA, USA),
according to the manufacturer’sp r o t o c o l .T h ee x p r e s -
sion of NS3 in the transfectants was determined by
western blot and immunofluorescence analysis.
To obtain an immunogen for the preparation of anti-
bodies against NS3, a truncated sequence (955 bp to
1857 bp) encoding the C-terminal region of the NS3
protein (NS3c) was amplified from plasmid Flag-NS3 by
PCR using the forward primer 5’-ATGAATT-
CATGCCGCCTGGAACCACGG-3’, and the reverse pri-
mer 5’- GCGTCGACTTATCTCTTCCCTGCTGCA-3’.
The amplified NS3c fragment was sub-cloned into the
EcoR I-Sal I cloning site of a prokaryotic expression vec-
tor pET-28a (Novagen, Madison, WI, USA) in order to
express the histidine (His)-tagged NS3c (His-NS3c) het-
erologously in Escherichia coli strain BL21 (DE3). The
expression was induced by treatment with 1 mM isopro-
pyl-b-D-thiogalactopyranoside (IPTG) at 37°C for 5 h,
and the expression product was purified using a His
Band kit (Novagen), according to the manufacturer’s
instructions. The purity of the preparation was assessed
by 10% sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis (SDS-PAGE) followed by staining with Coo-
massie blue R250.
Generation of polyclonal antibody
To prepare polyclonal antibodies against NS3, 6-week-
old ICR mice (n = 5) were immunized intraperitoneally
with 50 μg purified His-NS3c fusion protein emulsified
in complete Freund’s adjuvant (Sigma). Subsequent
booster immunizations of 50 μg purified His-NS3c in
incomplete Freund’s adjuvant (Sigma) were given intra-
peritoneally to each mouse on days 14, 28, and 42. The
mice were bled 7 days after the fourth immunization.
The titer of the antiserum was tested by ELISA. The
specificity of the antiserum was determined by western
blot and immunofluorescence analysis. The animal
experiments were in compliance with the Guidelines on
the Humane Treatment of Laboratory Animals (Ministry
of Science and Technology of the People’s Republic of
China, Policy No. 2006 398) and were approved by the
Institutional Animal Care and Use Committee at the
Shanghai Veterinary Research Institute, Chinese Acad-
emy of Agricultural Science.
Infection of JEV into mice
Three C57B/L6 sucking mice (1 week old) were inocu-
lated intraperitoneally with 0.1 ml of the SH-JEV01
strain of JEV (1.0 × 10
6 PFU). The mice showed neuro-
logical signs such as ataxia 4 days after inoculation. The
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according to the Guidelines on the Humane Treatment
of Laboratory Animals (Policy No. 2006 398). For
immunohistochemical examination, the brains of the
mice were collected and fixed in 10% neutral buffered
formalin. For western blot analysis, small pieces of
mouse brain were homogenized in a lysis buffer (20
mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM Na2-
EDTA, 1% Triton-100, 1 μg/ml leueptin, 1 μg/ml aproti-
nin, 1 mM PMSF). Two mice inoculated intraperitone-
ally with an equivalent volume of phosphate-buffered
saline were used as controls. The animal experiments
were in compliance with the Guidelines on the Humane
Treatment of Laboratory Animals (Policy No. 2006 398)
and were approved by the Institutional Animal Care and
Use Committee at the Shanghai Veterinary Research
Institute, Chinese Academy of Agricultural Science.
Immunohistochemistry
Mouse brain samples fixed in 10% neutral buffered for-
malin were processed routinely for preparation of paraf-
fin wax-embedded sections. The sections were stained
with primary antibody against NS3 for 30 min, and
incubated subsequently with a horseradish peroxidase-
conjugated goat anti-mouse IgG antibody (sc-2005,
Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 30
min. The sections were developed with 3, 3-diaminoben-
zidine (DAB) and examined with a light microscope.
The nuclei were counter-stained by hematoxylin.
ELISA
A microtiter plate was coated with 2 μg/ml of the puri-
fied His-NS3c fusion protein in carbonate-buffered sal-
ine and incubated overnight at 4°C. The plate was then
washed with phosphate-buffered saline (PBS) and
blocked with 1% bovine serum albumin (Sigma) in PBS.
After incubation, 100 μl of antiserum at different dilu-
tions were added to the appropriate wells and incubated
for 1 h at 37°C. The plate was washed and incubated for
1 h with the horseradish peroxidase-conjugated goat
anti-mouse IgG antibody (Santa Cruz) at 37°C. The
reaction was initiated by adding o-phenylenediamine
substrate solution (Sigma), and the absorbance at 490
nm was determined using a bichromatic microplate
reader.
Western blot and immunofluorescence analysis
Western blot and immunofluorescence analysis were
performed as described previously [20].
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